Literature DB >> 1472517

A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 3. Dental arch relationships.

M Mars1, C Asher-McDade, V Brattström, E Dahl, J McWilliam, K Mølsted, D A Plint, B Prahl-Andersen, G Semb, W C Shaw.   

Abstract

One hundred and forty-nine dental casts of subjects with complete unilateral clefts of the lip and palate from six European cleft palate centers were assessed by means of the Goslon Yardstick. The Yardstick proved capable of discriminating between the quality of the dental arch relationships between the six centers. Two centers showed especially poor results. Three centers obtained satisfactory results although differing surgical techniques were used in these centers. One of the centers showing satisfactory dental arch relationships employed a more complex and expensive treatment program than the other two centers, which both used simpler centralized treatment regimens.

Entities:  

Mesh:

Year:  1992        PMID: 1472517     DOI: 10.1597/1545-1569_1992_029_0405_asciso_2.3.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  23 in total

1.  Facial growth evaluation of complete unilateral cleft lip and palate operated patients: a cleft reference center in Paraíba, Brazil, using the "GOSLON" yardstick.

Authors:  Rosa Helena Wanderley Lacerda; Terumi Okada Ozawa; Tânia Braga Ramos; Paulo Germano Cavalcanti Furtado; Lindalva Alves de Oliveira; Andressa Feitosa Bezerra de Oliveira
Journal:  Oral Maxillofac Surg       Date:  2013-07-12

2.  Dental arch relationship in children with complete unilateral cleft lip and palate following one-stage and three-stage surgical protocols.

Authors:  Piotr Fudalej; Christos Katsaros; Catharina Bongaarts; Zofia Dudkiewicz; Anne Marie Kuijpers-Jagtman
Journal:  Clin Oral Investig       Date:  2010-05-15       Impact factor: 3.573

3.  Palatal growth changes in newborns with unilateral and bilateral cleft lip and palate from birth until 12 months after early neonatal cheiloplasty using morphometric assessment.

Authors:  Lenka Kožejová Jaklová; Eva Hoffmannová; Ján Dupej; Jiří Borský; Michal Jurovčík; Miloš Černý; Jana Velemínská
Journal:  Clin Oral Investig       Date:  2021-01-06       Impact factor: 3.573

Review 4.  Craniofacial malformations and the orthodontist.

Authors:  A Akram; M M McKnight; H Bellardie; V Beale; R D Evans
Journal:  Br Dent J       Date:  2015-02-16       Impact factor: 1.626

5.  Active Presurgical Infant Orthopedics for Unilateral Cleft Lip and Palate: Intercenter Outcome Comparison of Latham, Modified McNeil, and Nasoalveolar Molding.

Authors:  Michelle Kornbluth; Richard E Campbell; John Daskalogiannakis; Elizabeth J Ross; Patricia H Glick; Kathleen A Russell; Jean-Charles Doucet; Ronald R Hathaway; Ross E Long; Thomas J Sitzman
Journal:  Cleft Palate Craniofac J       Date:  2018-02-20

6.  Marked Variation Exists Among Surgeons and Hospitals in the Use of Secondary Cleft Lip Surgery.

Authors:  Thomas J Sitzman; Adam C Carle; Jaclyn N Lundberg; Pamela C Heaton; Michael A Helmrath; Carroll-Ann Trotman; Maria T Britto
Journal:  Cleft Palate Craniofac J       Date:  2019-10-09

Review 7.  Management of cleft lip and palate.

Authors:  A Habel; D Sell; M Mars
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

8.  Centralisation of services for children with cleft lip or palate in England: a study of hospital episode statistics.

Authors:  Kate J Fitzsimons; Shumaila Mukarram; Lynn P Copley; Scott A Deacon; Jan H van der Meulen
Journal:  BMC Health Serv Res       Date:  2012-06-10       Impact factor: 2.655

9.  External frame distraction osteogenesis of the midface in the cleft patient.

Authors:  Syed Altaf Hussain
Journal:  Indian J Plast Surg       Date:  2009-10

10.  Which index should be used to measure primary surgical outcome for unilateral cleft lip and palate patients?

Authors:  Timothy Jones; Sam Leary; Nikki Atack; Tony Ireland; Jonathan Sandy
Journal:  Eur J Orthod       Date:  2016-03-17       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.